Shrestha Sunil, Shrestha Rajeev, Ahmed Ali, Sapkota Binaya, Khatiwada Asmita Priyadarshini, Christopher Christina Malini, Thapa Parbati, Kc Bhuvan, Blebil Ali Qais, Khanal Saval, Paudyal Vibhu
School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500, Bandar Sunway, Selangor, Malaysia.
Department of Pharmacy, District Hospital Lamjung, Besisahar, Province Gandaki, Nepal.
J Pharm Policy Pract. 2022 May 10;15(1):37. doi: 10.1186/s40545-022-00431-1.
Pharmacists in high-income countries routinely provide efficient pharmacy or pharmaceutical care services that are known to improve clinical, economic, and humanistic outcomes (ECHO) of patients. However, pharmacy services in low- and middle-income countries, mainly South Asia, are still evolving and limited to providing traditional pharmacy services such as dispensing prescription medicines. This systematic review aims to assess and evaluate the impact of pharmacists' services on the ECHO of patients in South Asian countries.
We searched PubMed/Medline, Scopus, EMBASE, CINAHL, and Cochrane Library for relevant articles published from inception to 20th September 2021. Original studies (only randomised controlled trials) conducted in South Asian countries (published only in the English language) and investigating the economic, clinical (therapeutic and medication safety), and humanistic impact (health-related quality of life) of pharmacists' services, from both hospital and community settings, were included.
The electronic search yielded 430 studies, of which 20 relevant ones were included in this review. Most studies were conducted in India (9/20), followed by Pakistan (6/20), Nepal (4/20) and Sri Lanka (1/20). One study showed a low risk of bias (RoB), 12 studies showed some concern, and seven studies showed a high RoB. Follow-up duration ranged from 2 to 36 months. Therapeutic outcomes such as HbA1c value and blood pressure (systolic blood pressure and diastolic blood pressure) studied in fourteen studies were found to be reduced. Seventeen studies reported humanistic outcomes such as medication adherence, knowledge and health-related quality of life, which were found to be improved. One study reported safety and economic outcomes each. Most interventions delivered by the pharmacists were related to education and counselling of patients including disease monitoring, treatment optimisation, medication adherence, diet, nutrition, and lifestyle.
This systematic review suggests that pharmacists have essential roles in improving patients' ECHO in South Asian countries via patient education and counselling; however, further rigorous studies with appropriate study design with proper randomisation of intervention and control groups are anticipated.
高收入国家的药剂师常规提供高效的药学或药学服务,这些服务已知可改善患者的临床、经济和人文结局(ECHO)。然而,低收入和中等收入国家,主要是南亚国家的药学服务仍在发展,并且仅限于提供传统的药学服务,如分发处方药。本系统评价旨在评估和评价药剂师服务对南亚国家患者ECHO的影响。
我们在PubMed/Medline、Scopus、EMBASE、CINAHL和Cochrane图书馆中检索了从创刊到2021年9月20日发表的相关文章。纳入在南亚国家进行的(仅以英文发表)、调查药剂师服务在医院和社区环境中的经济、临床(治疗和用药安全)以及人文影响(与健康相关的生活质量)的原始研究(仅随机对照试验)。
电子检索产生了430项研究,其中20项相关研究纳入了本评价。大多数研究在印度进行(9/20),其次是巴基斯坦(6/20)、尼泊尔(4/20)和斯里兰卡(1/20)。一项研究显示偏倚风险(RoB)较低,12项研究显示有一些担忧,7项研究显示RoB较高。随访时间为2至36个月。在14项研究中研究的治疗结局,如糖化血红蛋白值和血压(收缩压和舒张压)有所降低。17项研究报告了人文结局,如用药依从性、知识和与健康相关的生活质量,这些均有所改善。一项研究分别报告了安全和经济结局。药剂师提供的大多数干预措施与患者教育和咨询有关,包括疾病监测、治疗优化、用药依从性、饮食、营养和生活方式。
本系统评价表明,药剂师通过患者教育和咨询在改善南亚国家患者的ECHO方面发挥着重要作用;然而,预计需要进一步进行严格的研究,采用适当的研究设计,对干预组和对照组进行适当随机分组。